Dual-Biomarker Blood Test Shows Promise for Pancreatic Cancer Early Detection

A new blood test that measures levels of two specific proteins may be able to accurately detect pancreatic cancer at its earliest stages, when it is most likely to respond to treatment, findings from a new study suggest.

Cancer Currents: An NCI Cancer Research Blog